Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing to Improve Outcomes for Patients With Limited Metastatic Disease That Failed First-Line Systemic Therapy

NCT06842030 is registered in ClinicalTrials.gov with Good Samaritan Hospital Medical Center, New York as lead sponsor.

NCT NCT06842030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06842030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing to Improve Outcomes for Patients With Limited Metastatic Disease That Failed First-Line Systemic Therapy
Lead sponsor
Good Samaritan Hospital Medical Center, New York
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 10, 2025
Completion date
April 10, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

feasibility, oligometastatic disease, personalized medicine